First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

被引：0
|
作者：
Flechner, S. M. [1 ]
Mulgaonkar, S. [2 ]
Melton, L. [3 ]
Wiseman, A. [4 ]
Sung, R. [5 ]
Waid, T. [6 ]
Shihab, F. [7 ]
Agarwal, A. [8 ]
Getts, Tegaue M. [9 ]
Getts, D. R. [9 ,10 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] St Barnabas Hosp, Livingston, NJ USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] Univ Colorado, Denver, CO 80202 USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ Kentucky, Lexington, KY USA
[7] Univ Utah, Salt Lak City, UT USA
[8] Univ Virginia, Charlottesville, VA USA
[9] Tolera Therapeut Inc, Kalamazoo, MI USA
[10] Northwestern Univ, Chicago, IL 60611 USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00188
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
434
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [41] Efficacy of tacrolimus once-daily dose LCTP (Envarsus®) formulation to prevent post kidney transplant diabetes in at-risk patients. Preliminary safety results
    Rodriguez-Fortunez, P.
    Rodriguez-Jimenez, C.
    Perez-Carreno, E.
    Masiero-Aparicio, P.
    Diaz-Martinez, L.
    Rodriguez-Adanero, C.
    Gonzalez-Rinne, A.
    Marrero, D.
    Perez-Tamajon, L.
    Rodriguez, A.
    Alvarez, A.
    de Bonis-Redondo, E.
    Fernandez-Rivera, C.
    Porrini, E.
    Torres-Ramirez, A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S113 - S114
  • [42] Safety and efficacy of CBV followed by autologous PBSC transplant in children with lymphoma after failed induction or first relapse - a children's oncology group study.
    Harris, RE
    Morris, E
    Warkentin, P
    Vlachos, A
    Chang, M
    Cairo, MS
    BLOOD, 2004, 104 (11) : 257A - 257A
  • [43] Efficacy and Safety of Extended-Duration Inpatient-to-Outpatient Rabbit Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients: 6-Month Outcomes
    Trofe-Clark, Jennifer
    Reese, Peter P.
    Patel, Hina J.
    Jakobowski, Diane
    Goral, Simin
    Doll, Stacey L.
    Abt, Peter L.
    Bloom, Roy D.
    TRANSPLANTATION, 2012, 94 (05) : 506 - 512
  • [44] Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study
    Custodio, Luciana de Fatima Porini
    Martins, Suelen Bianca Stopa
    Viana, Laila Almeida
    Cristelli, Marina Pontello
    Requiao-Moura, Lucio
    Chow, Charles Yea Zen
    Camargo, Suzana Friedlander Del Nero
    Nakamura, Monica Rika
    Foresto, Renato Demarchi
    Tedesco-Silva, Helio
    Medina-Pestana, Jose
    PEDIATRIC TRANSPLANTATION, 2024, 28 (03)
  • [45] Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study
    Kapoor, Rinky
    Shome, Debraj
    JOURNAL OF COSMETIC AND LASER THERAPY, 2018, 20 (06) : 369 - 379
  • [46] Once-Daily Envarsus Demonstrates Comparable Efficacy and Safety to Twice-Daily Prograf: A Phase 3 Study for Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients.
    Rostaing, L.
    Ciechanowski, K.
    Bunnapradist, S.
    Tedesco Silva, H.
    Grinyo, J.
    Budde, K.
    TRANSPLANTATION, 2014, 98 : 116 - 116
  • [47] Once-Daily Envarsus Demonstrates Comparable Efficacy and Safety to Twice-Daily Prograf: A Phase 3 Study for Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients.
    Rostaing, L.
    Ciechanowski, K.
    Bunnapradist, S.
    Silva, H. Tedesco
    Grinyo, J.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 116 - 116
  • [48] ONCE-DAILY LCP-TACRO DEMONSTRATES COMPARABLE EFFICACY AND SAFETY TO TWICE-DAILY PROGRAF: A PHASE 3 STUDY FOR PREVENTION OF ACUTE ALLOGRAFT REJECTION IN DE NOVO ADULT KIDNEY TRANSPLANT RECIPIENTS
    Rostaing, Lionel
    Budde, Klemens
    Ciechanowski, Kazimierz
    Bunnapradist, Suphamai
    Silva, Helio
    Grinyo, Josep Maria
    TRANSPLANT INTERNATIONAL, 2013, 26 : 171 - 171
  • [49] Efficacy and Safety of Glucose Like Peptide-1 Receptor Agonist (GLP1-RA) in Patients with Diabetes Who Underwent Kidney Transplantation (KT): A Potential Approach to Improve Post-Transplant Metabolic Outcomes
    Zelada, H.
    Campana, M.
    Redden, D.
    Kumar, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S563 - S563
  • [50] TTV GUIDE IT - A RANDOMISED CONTROLLED TRIAL TO COMPARE THE SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY BETWEEN STANDARD AND TORQUE TENO VIRUS-GUIDED IMMUNOSUPPRESSION IN STABLE ADULT KIDNEY TRANSPLANT RECIPIENTS WITH LOW IMMUNOLOGICAL RISK IN THE FIRST YEAR AFTER TRANSPLANTATION - A TRIAL PROTOCOL
    Haupenthal, Frederik
    Neuwirt, Hannes
    Eller, Kathrin
    Cejka, Daniel
    Banas, Bernhard
    Budde, Klemens
    Rotmans, Joris
    Rostaing, Lionel
    Malvezzi, Paolo
    Bakker, Stephan
    Viklicky, Ondrej
    Beneyto, Isabella
    Ohlmann, Sophie
    Bourgeois, Philippe
    Del Alamo, Marta
    Navarro, David
    Rodriguez-Arias, David
    Maggi, Fabrizio
    Graehlert, Xina
    Puchhammer-Stoeckl, Elisabeth
    Regele, Heinz
    Vossen, Matthias
    Boehmig, Georg
    Wolzt, Michael
    Jilma, Bernd
    Herkner, Harald
    Koenig, Franz
    Hugo, Christian
    Bond, Gregor
    TRANSPLANT INTERNATIONAL, 2021, 34 : 4 - 4
12345